Skip to content
Synopulse
  • The Brief
    • Quick
    • In Depth
    • Editor’s Pick
    • Findings
  • Reports
    • The beats
      • Catalyst
      • AccessWatch
      • DealPulse Signal
      • DealPulse Report
    • Analysis
      • The Throughline
      • The Top Line
      • The Forecast
    • Coverage
      • ShowFloor
      • The Arena
  • The Pulse
    • NeuroPulse
    • OrphanPulse
  • Topics
    • By subject
      • Deals
      • Regulatory
      • Market Access
      • Pricing & Reimbursement
      • Legal & Policy
    • By technology
      • Antibody
      • Cell & Gene Tx
      • Drug conjugates
      • AI/ML
      • Digital Health
      • Radiopharma
    • By therapy area
      • Neurology
      • Oncology
      • Rare Diseases
      • Cardio-Metabolic
      • Immunology & Inflammation
      • Orthopaedics
Logical Reasoning Survived Severe Aphasia, and Recruited No Language Regions in Healthy Brains
Logical Reasoning Survived Severe Aphasia, and Recruited No Language Regions in Healthy Brains
Athithi Verma August 12, 2026
Two patients with severe aphasia solved formal logic problems as well as controls. The language network stayed quiet through both reasoning types.
Korea Cleared Two Diagnostics on One Day, and Both Remove a Specialist
Korea Cleared Two Diagnostics on One Day, and Both Remove a Specialist
FastWave's Pivotal Trial Cannot Measure the Thing FastWave Is Selling
FastWave’s Pivotal Trial Cannot Measure the Thing FastWave Is Selling
The MHRA Authorised Two Obesity Drugs in Two Days. Neither Is on the NHS.
The MHRA Authorised Two Obesity Drugs in Two Days. Neither Is on the NHS.
CMS Opened a Same-Day Coverage Lane for Devices and Closed the Payment Route Underneath It
CMS Opened a Same-Day Coverage Lane for Devices and Closed the Payment Route Underneath It
Washington Narrowed the Childhood Schedule, and the Insurer Backstop Quietly Stopped Being One
Washington Narrowed the Childhood Schedule, and the Insurer Backstop Quietly Stopped Being One

Editor’s Pick

AstraZeneca Announced Nothing. The Market Charged It $24bn Anyway.

AstraZeneca Announced Nothing. The Market Charged It $24bn Anyway.

Congress Exempted the Medically Frail. The Coding System Cannot Find Them.

Congress Exempted the Medically Frail. The Coding System Cannot Find Them.

Britain Thought It Had an Opt-Out. Washington Reads the Deal Differently.

Britain Thought It Had an Opt-Out. Washington Reads the Deal Differently.

NeuroPulse


NeuroPulse Wk 32: Takeda Fixed the Cause, and Cannot Ship It Yet

NeuroPulse Wk 32: Takeda Fixed the Cause, and Cannot Ship It Yet

NeuroPulse Wk 31: An Open-Label 77% Could Not Rescue a Missed Endpoint

NeuroPulse Wk 31: An Open-Label 77% Could Not Rescue a Missed Endpoint

OrphanPulse


OrphanPulse Wk 32: Tarsus Paid $450M Upfront for a Readout in 2029

OrphanPulse Wk 32: Tarsus Paid $450M Upfront for a Readout in 2029

OrphanPulse Wk 31: The Panel Voted on a Process, Not a Drug

OrphanPulse Wk 31: The Panel Voted on a Process, Not a Drug

DealPulse Signal


DealPulse Signal Wk 32: Private Equity Took the Week and Paid Cash for All of It

DealPulse Signal Wk 32: Private Equity Took the Week and Paid Cash for All of It

DealPulse Signal Wk 31: One Buyer Paid Everything, Another Paid a Fifth

DealPulse Signal Wk 31: One Buyer Paid Everything, Another Paid a Fifth

DealPulse Report


DealPulse Report July 2026: Vertex Pays 102% as Oncology Cedes the Lead

DealPulse Report July 2026: Vertex Pays 102% as Oncology Cedes the Lead

DealFlow H1 2026 M&A Doubles as Upfront Spending Hits $174B

DealFlow H1 2026: M&A Doubles as Upfront Spending Hits $174B

The Beats


DealPulse Signal Wk 32: Private Equity Took the Week and Paid Cash for All of It

DealPulse Signal Wk 32: Private Equity Took the Week and Paid Cash for All of It

DealPulse Report July 2026: Vertex Pays 102% as Oncology Cedes the Lead

DealPulse Report July 2026: Vertex Pays 102% as Oncology Cedes the Lead

DealPulse Signal Wk 31: One Buyer Paid Everything, Another Paid a Fifth

DealPulse Signal Wk 31: One Buyer Paid Everything, Another Paid a Fifth

Analysis


Reshaping Pharma by 2027

7 Market Access Trends Reshaping Pharmaย by 2027

The Biologics Patent Cliff: Inside Pharma's 2026-2029 Reckoning

The Biologics Patent Cliff: Inside Pharma’s 2026-2029 Reckoning

Coverage


The ADC Decade Accelerates What to Watch at ASCO 2026

The ADC Decade Accelerates: What to Watch at ASCO 2026

The Briefs

Logical Reasoning Survived Severe Aphasia, and Recruited No Language Regions in Healthy Brains

Logical Reasoning Survived Severe Aphasia, and Recruited No Language Regions in Healthy Brains

Athithi Verma August 12, 2026
Korea Cleared Two Diagnostics on One Day, and Both Remove a Specialist

Korea Cleared Two Diagnostics on One Day, and Both Remove a Specialist

Athithi Verma August 12, 2026
FastWave's Pivotal Trial Cannot Measure the Thing FastWave Is Selling

FastWave’s Pivotal Trial Cannot Measure the Thing FastWave Is Selling

Athithi Verma August 12, 2026
The MHRA Authorised Two Obesity Drugs in Two Days. Neither Is on the NHS.

The MHRA Authorised Two Obesity Drugs in Two Days. Neither Is on the NHS.

Athithi Verma August 12, 2026
CMS Opened a Same-Day Coverage Lane for Devices and Closed the Payment Route Underneath It

CMS Opened a Same-Day Coverage Lane for Devices and Closed the Payment Route Underneath It

Athithi Verma August 12, 2026
Washington Narrowed the Childhood Schedule, and the Insurer Backstop Quietly Stopped Being One

Washington Narrowed the Childhood Schedule, and the Insurer Backstop Quietly Stopped Being One

Athithi Verma August 12, 2026
Read More
Synopulse
Contact Us

Explore Synopulse

  • NeuroPulse
  • Deals
  • Market Access
  • Industry Trends
  • Regulatory

About

  • About Synopulse
  • Contact Us
  • Announcements
© 2026 Synopulse • Built with GeneratePress